Dr Craig Cook has more than 15 years of international experience in the pharma, biomedical and high technology sectors including roles across a range of therapeutic areas, such as neurology, inflammatory, immunology, and endocrine, covering both drug development and medical affairs. He has established and led several healthcare initiatives, and held increasingly senior appointments at Johnson & Johnson, Eli Lilly, Novartis Pharma, and Serono Biotech.
He served as Chief Executive Officer of dual listed (AIM & NASADAQ) Midatech Pharma PLC and Board Director as of June 1, 2018 to March 2020. He currently serves as CEO of Finnish based Herantis Pharma, focused on the treatment of Parkinson’s disease, other neurodegenerative diseases, and of secondary lymphedema.
Craig co-founded Spacecode with Pavlo Protopapa and served as CEO until 2013. He is a qualified physician, has a BSc in Pharmacology, Diploma in Anaesthesiology, and an MBA from the London Business School. He joined Midatech Pharma in 2014 and serves as Chief Executive Officer and Board Director as of June 1, 2018.